Home

Akums Drugs & Pharmaceuticals Ltd EPS

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

EPS

₹ 20.49

Last updated on: Jul 04, 2025

Key Highlights

  • The Earning per Share of Akums Drugs & Pharmaceuticals Ltd is ₹ 20.49 as of 04 Jul 25 .
  • The earning per share of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -13.16 to ₹ 9.64 over 8 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

Market Cap

9,094 Cr

EPS

20.5

P/E Ratio (TTM)

28.2

P/B Ratio (TTM)

3.0

Day’s High

583.0

Day’s Low

569.95

DTE

0.0

ROE

11.1

52 Week High

1174.85

52 Week Low

407.4

ROCE

12.0

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Jul 2025577.8
03 Jul 2025581.25
02 Jul 2025575.6
01 Jul 2025574.7
30 Jun 2025584.6
27 Jun 2025593.35
26 Jun 2025583.25
25 Jun 2025573.8
24 Jun 2025536.6
23 Jun 2025534.6

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

9,094

Asset Value

Value addition

2.7 X

2,483

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Akums Drugs & Pharmaceuticals Ltd9094
Sun Pharmaceutical Industries Ltd402285
Divis Laboratories Ltd183268
Cipla Ltd122247
Torrent Pharmaceuticals Ltd113983
Dr Reddys Laboratories Ltd108921

Historical Market Cap of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Akums Drugs & Pharmaceuticals Ltd News Hub

Akums Drugs and Pharmaceuticals rises on debut

The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has

Read more

06 Aug 24

Akums Drugs and Pharmaceuticals IPO ends with strong subscription

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha

Read more

02 Aug 24

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha

Read more

01 Aug 24

Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202

Read more

26 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Akums Drugs & Pharmaceuticals Ltd

What is the EPS of Akums Drugs & Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Akums Drugs & Pharmaceuticals Ltd is 20.49. An EPS is the amount of net income attributed to each share of a common stock.

How is Akums Drugs & Pharmaceuticals Ltd EPS calculated?

The EPS of Akums Drugs & Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Akums Drugs & Pharmaceuticals Ltd report its EPS?

Akums Drugs & Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Akums Drugs & Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Akums Drugs & Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Akums Drugs & Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Akums Drugs & Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions